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ABSTRACT 
 
This paper examines health care utilization among elderly people in sixteen European countries using 
the last wave of the Survey of Health, Ageing and Retirement in Europe (SHARE). Negative 
Binominal regression is conducted to study the main driving factors behind health care utilization 
(visits to the General Practitioners, GP; Hospital Stays, HS). The empirical results suggest that age, 
gender, education level, self-assessed health, health limitations and status and other socioeconomic 
variables are the main driving factors. We also show that socioeconomic variables do not play the 
same role in every country. From a policy economic approach, we propose important information to 
the current debates both in the health economics and social welfare literature. Our findings are relevant 
and have several implications for policy purposes to enhance efficiency, equity and quality of health 
care that it can be provided.  
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1. INTRODUCTION 
 
Population aging has become one of the most important topics in our society since it is 
expected that the ratio of elderly people over all the population rises from 18% to 28% by 2060 [1]. The 
European Union is concerned about how these projections are going to affect health care services [2, 3] 
because elderly people are prone to use more the health care system [4-5] 
Therefore, the future of the European health care services depends on national provision of care 
and the ways that they are organized and financed [6-10]. These health care systems (National Health 
Services or Social Security Systems) have a great relevance since there is some evidence that the use 
of health care services differs between public and private sector [11]. Besides, depending on the 
country, a prescription by the GP is needed to visit a specialist [12] and this waiting time can increase 
the use of emergency services. These differences can be related with income inequalities [13], which 
is an important factor determining the health care services utilization. A low-income household must 
wait till the public system can provide them an appointment but a high-income one can use the private 
sector and get a faster health care service [14]. The economic status is also a factor behind some mental 
diseases [15] like dementia or depression which are proved to be the most typical conditions affecting 
elderly people [16-20]. 
Hence, the purpose of this study is to examine the main drivers of health care utilization 
measured by the visits to the General Practitioners (GP) and the Hospital Stays (HS). Once an analysis 
for the European Union as a whole is done, we focus on the 16 member states which we have data for 
based on a multinational Survey, the last wave of the Survey of Health, Ageing and Retirement in 
Europe (SHARE), which provides comparable Gross National individual data. The SHARE sample is 
nationally representative of individuals who are 50 years old and over. This is an important fact since 
that using SHARE it is possible to disentangle whether all Member States follow a European pattern in 
the use of healthcare system.  
Our main contributions are as follows. Firstly, the drivers of the visits to the GP and the 
hospital stays are based on the last wave (6thwave) of the SHARE. It does not only include an analysis 
for each Member State because we also treat the European Union as a whole.  Secondly, we analyze if 
there is a similar pattern in the European Union Member States, proposing that similar policy 
recommendations for the European Union Member States is not always a good idea (One-size-fits-all 
policy) 
The paper is organized as follows. The second section is based on the theoretical framework, 
methodology and data where our topic is analyzed. The third section is focused on the empirical 
analysis and a discussion of the results can be found. And finally, the final one presents the conclusions 
and policy implications. 
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2. METHODOLOGY AND DATA 
 
Methods 
Count data methods are often used to explain the healthcare utilization [21-24] and it is useful 
for cases like the European health care services (Table 1). Our aim is explaining the variables GP 
(number of visits to the General Practitioner) and HS (hospital stays understood as number of nights a 
person is hospitalized). The estimation is based on two different distributions that are both estimated by 
maximum likelihood: Poisson and Negative Binomial. Since Poisson models have the property of 
equidistribution and has heterokedasticity a parameter capable to capture the randomness is introduced. 
The binomial negative function of density is the following:  Pr(Yi = yi|xi) =  Γ(yi + νi)Γ(yi + 1)Γ(νi) ( νiνi + µi )νi( µiνi + µ)yi 
Where 
µi = E(Yi|xi) =  𝑒𝑒𝑒𝑒𝑒𝑒(xi𝛽𝛽) 
νi =  1α µi𝑡𝑡       t = 0,1 
 
Depending on the way we define the variance there are two possibilities:  
 
ν = (1/α) 
Then E(Yi|xi) =  𝑒𝑒𝑒𝑒𝑒𝑒(xi𝛽𝛽) Var(Yi|xi) = (1 + α)𝑒𝑒𝑒𝑒𝑒𝑒(xi𝛽𝛽) 
Or  Var(Yi|xi) = 𝑒𝑒𝑒𝑒𝑒𝑒(xi𝛽𝛽)(1 + α𝑒𝑒𝑒𝑒𝑒𝑒(xi𝛽𝛽)) 
 
If the parameter α tends to 0, then it would be a Poisson distribution. It can be tested with a 
equidispersion contrast (H0: α = 0). If α > 0,  then overdispersion and infra dispersion if α < 0 
 
Zero-inflated model are used for NH. The weight given to fact that the probability the variable 
equals zero is higher in comparison to the other specifications [25] and it is assumed that zeros are not 
generated by the same process than the other observations [24]. It can be specified as follows: 
𝑃𝑃(𝑌𝑌𝑖𝑖  =  0)  =  𝑓𝑓1(0) 
𝑃𝑃(𝑌𝑌𝑖𝑖  =  𝑦𝑦𝑖𝑖) = �1 −  𝑓𝑓1(0)� 𝑓𝑓2(𝑦𝑦𝑖𝑖)1 − 𝑓𝑓2(0)           𝑦𝑦𝑖𝑖 = 1,2, … 
Where 𝑓𝑓1()  and 𝑓𝑓2() are probability functions and 1 − 𝑓𝑓2() is used to truncate on zero. 
 
 
(2) 
(3) 
(4) 
(7) 
(6) 
(5) 
(8) 
(9) 
(1) 
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Data 
Our data came from the 6th wave of the Survey of Health, Aging and Retirement in Europe 
(SHARE) [26,27]. One of the novelties of this new wave is that a new country has been included: 
Croatia. The SHARE survey is the result of the aim of the European institutions to have a deeper and 
strongest cooperation with Member States to have good data on elderly people. It covers data from 
health to socioeconomic status passing through lifestyle which will helps us to include more 
determinants of the health care utilization system. In the Table 2, there is a summary of the most 
important statistics for each relevant variable. Our dependent variables are based on two health care 
indicators (GP and HS).  
Moreover, since age has a major impact on the health care utilization and it is different 
among different groups of age, for the EU we have distinguished between four groups: 50-65, 65-75, 
75-85 and +85. In the case of each European country, we include the age as an independent variable 
with the addition of another variable AGE2 that is the squared of Age in order to consider the 
quadratic relationship of this variable along lifecycle with our dependent variables.  
As previous studies [12, 16, 22], we include gender (Female), marital status (Single), 
participation in the labor market (InLabFor) and the level of education (PriEduc, SecEduc and 
TerEduc), as relevant variable although this last one could be correlated with the socioeconomic level 
of individuals. Because of among the European Union there are different health care systems, we 
include a dummy variable related with a supplementary insurance (SupInsu) could be interesting to 
understand whether having it or not would affect to the use of the public service.  
Multimorbidity has been captured through some proxies: the Number of Chronic Diseases a 
person has (NCD), and the number of limitations in Activities of Daily Living a person has (ADL). 
The self-assessed health has been included in the case of being with good health (SPGH). Physical 
characteristics determine the physical health status and we have included four dummies: Underweight 
(UW), NormalWeight (NW), Overweight (OW) and Obese (Obese). At this regard, we use the Body 
Mass Index (BMI) that is included in the SHARE survey and then people were classified depending 
whether their BMI was under 18.5 (UW), between 18.5 and 25 (NW), between 25 and 30 (OW) and 
more of 30 that corresponds to people suffering from obesity [28]. Hence, the importance of obesity 
has a double side: first, the direct effect that the illness has and the second is the propensity that people 
included in this condition could suffer from diabetes or other sicknesses which can make citizens 
request to have a higher coverage that includes specialists like dieticians or psychologists. [29-32]. 
Finally, Lifestyle is also important in the predisposition of getting ill and in this case the proxy 
variable selected was related to smoking (Smoke). 
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3. EMPIRICAL RESULTS 
 
Visits to General Practitioner (GP) 
 In this section, we compare our findings with those concerning with health care utilization 
using count data models. Our estimates show in Tables 3 and 4 that , being a female is related to more 
possibilities of going to the GP that men since they are more likely to be ill from disabling conditions 
[33]. This gender gap decreases along our sample and turns negative for the group of people of more 
than 85 years old. It could be possible since women have a longer life expectancy than men, 83.3 and 
77.9 respectively [34]. It mean that those men that are older than 85 has subjective health that it 
continues to be substantially worse than women which leads them to visit more to the GP as previous  
studies has demonstrated [35,36]. 
 Being single has different effects along the cohorts. It produces more GP visits in those people 
aged 50-65 and +85 and less in the other cases. Marital status is not relevant in any country (excepting 
for Croatia and Czech Republic) and it does not have a similar slope because in some countries it is 
negative an in others it is positive probably due to the heterogeneity in cultures 
Moreover, active people are less prone to visit GPs and this effect increases when people gets 
older. This result is consistent with some previous literature where it was proved that unemployed 
people were more alike to use the health care services [37]. The fact of having a supplementary 
insurance is related with more visits to the GPs and education variables also are important.  
Self-assessed health, number of chronic diseases and limitations of daily living are statistically 
significant in all the elderly groups which mean that they are main driving factors of health care 
utilization. It is important to notice that most of their values get reduced when changing the cohort but 
continue having the same relevance. More chronic diseases and limitations increase the probability of 
visit the GP and having a good self-assessed health has the opposite effect. Besides, when smoke is 
significant, we can observe that it has a positive slope which is consistent with the previous literature. 
The same can be argued to those people that do not have a normal BMI. Generally, there are more 
likely to visit the GP than those with a normal weight. 
 
Hospital Stays (HS) 
 
There are wide variations across European countries in Hospital Stays differences as it shows 
Tables 5-6. Being female is related to have less hospital stays than men and being single, although is 
only statistically relevant in the general European Union analysis increases the probability of having 
more hospital stays. As in the case for GP visits, age is the main driving factor of health care utilization 
but here we observe that… 
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Being in the labor force reduces, in general, the probability of being hospitalized. For the group 
of people aged between 75 and 85 it is not a relevant factor, something that can be explained because 
there are not so many people working at that age, and those who continue active in the labor market 
may have a fantastic health status.  
The health care system (National Health Services or Social Security System) could be also 
behind the differences in the effect of having a supplementary insurance and its influence over health 
care utilization. Hence, poor people cannot get a supplementary insurance as the people with a higher 
socioeconomic status. Related with the proxies of the socioeconomic status, we can point out that those 
people with tertiary education have less probability of having hospital stays than those with a lower 
education. Being hospitalized can be consequence of not have treated correctly an illness.  
Finally, health status measured by multimorbidity and limitations of daily living and the self-
assessed health are main driving factors of health care utilization according to our findings which are 
consistent with previous literature [36-38]. The first two ones have a clear positive effect on the 
probability of being hospitalized but a good self-assessed health decrease the probability of being 
hospitalized. Variables related to BMI are not relevant enough although not having a normal BMI 
increase HS. The same happens with the variable related with smoke proxy because it is only 
significant in the first group of age and in some countries although their slope is generally positive. 
 
4. CONCLUSIONS 
 
The comparison of the elderly people and some socioeconomic variables regarding their health 
care utilization in Europe is studied here in order to provide new empirical evidence. We demonstrate 
that the drivers behind the visits to the General Practitioner and Hospital Stays by using the 6thwave of 
the SHARE are quite similar to those described in the previous literature. Our findings point to the fact 
that there is a similar pattern in the European Union Member States.  
Being older increase the health care utilization and being part of the labor force reduces the use 
of the healthcare system. People with chronic diseases and limitations in their daily activities make 
them visit more the General Practitioner and to have longer Hospital Stays. But other factors as 
education, marital status, gender or supplementary insurance can influence health care utilization in 
order to reduce it.  
The results of this research add to our understanding of the behavior about health care 
utilization of elderly people across Europe. We really think that health campaigns, a better use of digital 
medicine or to empower patients to take care by themselves should be designed to explain to the people 
how health care (primary and hospital) should be used. Because of the heterogeneous nature of General 
Practitioner visits and Hospital Stays in Europe and the increasing pressure of a growing elderly 
population, more effort in this direction has to be carried out in order to enhance efficiency, equity and 
quality of health care systems. 
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Table 1. Health care models in the European Union (Countries) 
 
 
 
 
 
 
 
Country Acronym System 
Austria AT 
Social security. 99%of population is covered. Financed 
by sickness funds (59%), taxation (24%), private 
insurance (7.5%) and co-payments 
Belgium BE 
Social security. Entire population is covered. Financed 
by social health insurance, general taxation and out-of-
pocket payments 
Croatia CRO 
Mandatory Health Insurance. Universal coverage. 
Financed by compulsory contributions (75%) and state 
budget (15%) and debt. 
Czech Republic CR Statutory Health Insurance. Compulsory membership. Financed by wage-based contributions, 
Denmark DE National Health Service. Entire population is covered. Financed by general taxation 
Estonia ES Estonian health system. Universal access. Financed by social payroll tax and public budget. 
France FR 
National Health Insurance. Entire population is covered. 
Mix between private and public. Financed by 
employees’ payroll taxes, co-payments 
Germany  GE 
Compulsory social insurance. Financed by compulsory 
and voluntary contributions to statutory health insurance 
(60%), general taxation (21%) and other payments 
Greece  GR Compulsory social insurance. Financed by general taxation and social insurance. 
Italy  IT 
National Health Service. Universal access. Financed by 
social insurance (40%), general taxation (35%) and co-
payments. 
Luxembourg LU Assurance Maladie. Financed by contributions to social sickness funds 50-50 employer and employee 
Poland PL Social Health Insurance. Universal coverage. Financed by SHI contributions 
Portugal PO National Health System. Universal coverage. Financed by general taxation (62%) and social insurance 
Slovenia SL Health Insurance Institute of Slovenia. Universal coverage 
Spain SP 
National Health System. Universal coverage. Financed 
by general taxation (80%), work-related contributions 
(18%) and co-payments. 
Sweden  SW 
National Insurance Scheme. Universal coverage. 
Financed by income taxes (65%) the rest state funds, 
subsidies and private insurance 
Source: Authors´ elaboration from ´[39-45]: European Parliament (1998),Sagan et al (2011),  Kinkorova (2012), 
Lai et al (2013), Dzakula et al (2014), Alexa et al (2015),  and OECD Health Systems Characteristics Survey (2016) 
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Table 2. Variables and summary of statistics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Variable Mean Stand. Dev Description 
Dependent Variables   
    
GP 6.7 9.136 Number of visits to the General Practitioner in 365 days 
HS 1.781 9.1667 Hospital Stays: Number of Nights at Hospital in 365 days 
    
Independent Variables   
    
Age 67.865 10.059 Age (years) 
Female 0.560 0.496 1 if female, 0 otherwise 
Single 0.291 0.454 1 if single, 0 otherwise 
    
InLabFor 0.272 0.445 1 if in labor force, 0 otherwise 
SupInsu 0.347 0.476 1 if has a supplementary insurance, 0 otherwise 
PriEduc 0.367 0.481 1 if Primary School, 0 otherwise 
 SecEduc 0.538 0.498 1 if Secondary School, 0 otherwise 
TerEduc 0.095 0.293 1 if Tertiaty Education, 0 otherwise 
    ADL 0.280 0.939 Number of Limitations in Activities of Daily Living 
NCD 1.896 1.623 Number of Chronic Diseases 
SPGH 0.591 0.492 1 if Self-Assessed (Good Health), 0 otherwise 
    
UW 0.011 0.106 1 if UnderWeight, 0 otherwise 
NW 0.344 0.475 1 if NormalWeight, 0 otherwise 
OW 0.418 0.493 1 if OverWeight, 0 otherwise 
OB 0.226 0.418 1 if Obese, 0 otherwise 
    
Smoke 0.448 0.497 1 if ever smoked, 0 otherwise 
Source: Authors' calculation based on SHARE 6th wave (N=62,554).  
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Table 3. Negative Binomial estimates. European Union. GP as dependent 
variable 
Variable 
50-65  
years 
 
65-75 
years 
  
75-85 
years    
 
+85 
years      
 
Female 
0.139 *** 
(0.016) 
0.015 
(0.017) 
0.002 
(0.024) 
-0.077 
(0.051) 
Single 
0.059 *** 
(0.019) 
-0.025 
(0.018) 
-0.034 
(0.023) 
0.059 
(0.045) 
SupInsu 
0.145 *** 
(0.016) 
0.087 *** 
(0.017) 
0.025 
(0.022) 
0.089 ** 
(0.040) 
SecEduc 
0.029 (0.018) -0.001 (0.017) 
0.046 ** 
(0.021) 
0.035 
(0.040) 
TerEduc 
0.115 *** 
(0.028) 
0.054 * 
(0.030) 
0.097 ** 
(0.044) 
0.208 ** 
(0.088) 
ADL 
0.137 *** 
(0.015) 
0.087 *** 
(0.012) 
0.098 *** 
(0.011) 
0.082 *** 
(0.012) 
NCD 
0.257 *** 
(0.006) 
0.184 *** 
(0.006) 
0.141 *** 
(0.006) 
0.115 *** 
(0.011) 
SPGH 
-0.511 *** 
(0.019) 
-0.439 *** 
(0.018) 
-0.295 *** 
(0.023) 
-0.226 *** 
(0.042) 
UW 
0.164 * 
(0.090) 
0.151 * 
(0.087) 
0.136 
(0.091) 
0.054 
(0.121) 
OW 
-0.054 *** 
(0.018) 
0.044 ** 
(0.019) 
0.022 
(0.024) 
-0.031 
(0.041) 
OB 
-0.011 
(0.021) 
0.058 *** 
(0.021) 
0.006 
(0.027) 
-0.028 
(0.055) 
Smoke 
0.002  
(0.015) 
0.015 
(0.016) 
0.045 * 
(0.023) 
0.078 * 
(0.046) 
constant 
1.463 *** 
(0.032) 
1.620 *** 
(0.029) 
1.728 *** 
(0.034) 
1.769 *** 
(0.062) 
alpha 
0.775  
(0.012) 
0.650 
(0.011) 
0.677 
(0.013) 
0.747 
(0.025) 
N 
26,976 21,063 12,436 3,305 
Notes: Standard deviations are in parentheses. ***, **, *, are the significance at level 1,5 and 10% 
respectively 
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Table 4. Negative Binomial estimates. European Countries. GP as dependent variable 
Variable AT BE CRO CR DE ES FR GE  
Age 0.041 *** 
(0.004) 
-0.093 *** 
(0.021) 
0.043 *** 
(0.005) 
0.047 *** 
(0.003) 
0.034 *** 
(0.005) 
0.045 *** 
(0.003) 
0.043 *** 
(0.004) 
-0.054 ** 
(0.024) 
Age2 -0.001 *** 
(0.000) 
0.001 *** 
(0.000) 
-0.001 *** 
(0.000) 
-0.003 *** 
(0.000) 
-0.001 *** 
(0.000) 
-0.004 *** 
(0.000) 
-0.001 *** 
(0.000) 
0.001 ** 
(0.000) 
Female 0.066 
(0.041) 
0.113 *** 
(0.034) 
0.084 
(0.054) 0.036 (0.029) 
0.049 
(0.042) 
0.045 
(0.038) 
0.059 * 
(0.034) 
0.045 
(0.034) 
Single 0.017 
(0.044) 
0.014 
(0.033) 
0.024 
(0.081) 
-0.022 
(0.031) 
0.033 
(0.043) 
-0.044 
(0.036) 
0.001 
(0.037) 
0.019 
(0.041) 
InLabFor 0.003 
(0.064) 
-0.312 *** 
(0.049) 
-0.039 
(0.071) 
-0.088 ** 
(0.042) 
-0.031 
(0.059) 
-0.074 * 
(0.044) 
-0.003 
(0.049) 
-0.179 *** 
(0.051) 
SupInsu 0.137 *** 
(0.047) 
0.174 *** 
(0.039) 
0.326 *** 
(0.326) 
-0.012 
(0.058) 
0.006 
(0.043) 
0.111 
(0.085) 
0.075 
(0.109) 
0.093 ** 
(0.038) 
SecEduc 0.046 
(0.042) 
-0.078 * 
(0.042) 
-0.094 * 
(0.055) 
0.076 ** 
(0.037) 
0.117 * 
(0.063) 
0.014 
(0.042) 
0.049 
(0.037) 
0.076 
(0.053) 
TerEduc 0.039 
(0.069) 
-0.046 
(0.057) 
-0.109 
(0.142) 
0.124 ** 
(0.049) 
0.147 * 
(0.086) 
0.213 *** 
(0.077) 
0.069 
(0.056) 
0.146 ** 
(0.071) 
ADL 0.126 *** 
(0.025) 
0.124 *** 
(0.024) 
0.030 
(0.032) 
0.069 *** 
(0.020) 
0.095 ** 
(0.038) 
0.093 *** 
(0.016) 
0.108 *** 
(0.020) 
0.073 *** 
(0.021) 
NCD 0.187 *** 
(0.013) 
0.155 *** 
(0.010) 
0.306 *** 
(0.018) 
0.188 *** 
(0.010) 
0.276 *** 
(0.276) 
0.204 *** 
(0.011) 
0.136 *** 
(0.012) 
0.165 *** 
(0.012) 
SPGH -0.332 *** 
(0.043) 
-0.521 *** 
(0.038) 
-0.397 *** 
(0.054) 
-0.343 *** 
(0.031) 
-0.571 *** 
(0.056) 
-0.496 *** 
(0.047) 
-0.483 *** 
(0.045) 
-0.533 *** 
(0.039) 
UW 0.445 ** 
(0.205) 
0.093 
(0.116) 
0.212 
(0.364) 
-0.355 ** 
(0.154) 
0.194 
(0.189) 
-0.029 
(0.122) 
-0.001 
(0.096) 
-0.148 
(0.147) 
OW -0.039 
(0.047) 
0.085 ** 
(0.036 
-0.038 
(0.063) 
-0.001 
(0.036) 
0.076 
(0.047) 
-0.027 
(0.043) 
0.010 
(0.039) 
0.052 
(0.037) 
OB 0.029 
(0.055) 
0.068 
(0.044) 
0.026 
(0.071) 
-0.018 
(0.039) 
0.065 
(0.057) 
0.069 
(0.047) 
0.043 
(0.043) 
0.061 
(0.049) 
Smoke 0.024 
(0.041) 
0.075 ** 
(0.033) 
-0.062 
(0.055) 
-0.005 
(0.028) 
-0.034 
(0.042) 
0.031 
(0.036) 
0.058 * 
(0.033) 
-0.002 
(0.033) 
alpha 0.688 (0.029) 
0.623 
(0.020) 
0.979 
(0.044) 0.470 (0.017) 
0.705 
(0.030) 
0.753 
(0.027) 
0.399 
(0.024) 0.587 
N  3,266 5,370 2294 4,612 3,499 5,356 3,718 4,233 
Notes: Standard deviations are in parentheses. ***, **, *, are the significance at level 1,5 and 10% respectively. Table 1: what countries correspond to each acronym 
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Table 4. Negative Binomial estimates. European Countries. GP as dependent variable (continuation) 
Variable GR  IT LU PL PO SL SP SW  
Age 0.025 *** 
(0.003) 
0.053 *** 
(0.003) 
0.055 *** 
(0.005) 
0.051 *** 
(0.005) 
0.027 *** 
(0.006) 
0.051 *** 
(0.004) 
0.045 *** 
(0.003) 
0.037 *** 
(0.005) 
Age2 -0.001 *** 
(0.000) 
-0.001 *** 
(0.000) 
-0.001 *** 
(0.000) 
-0.003 *** 
(0.000) 
-0.0001 
(0.000) 
-0.004 *** 
(0.000) 
-0.003 *** 
(0.000) 
-0.001 *** 
(0.000) 
Female 0.161 *** 
(0.041) 
0.096 *** 
(0.037) 
0.153 ** 
(0.063) 
0.099 * 
(0.055) 
-0.005 
(0.069) 
-0.010 
(0.043) 
-0.043 
(0.038) 
-0.087 * 
(0.052) 
Single 0.047 
(0.043) 
0.011 
(0.041) 
0.152 ** 
(0.076) 
-0.125 ** 
(0.059) 
-0.109 
(0.074) 
-0.027 
(0.050) 
-0.022 
(0.042) 
0.028 
(0.057) 
InLabFor -0.232 *** 
(0.050) 
-0.225 *** 
(0.048) 
0.055  
(0.084) 
-0.337 *** 
(0.072) 
0.009 
(0.073) 
0.092 
(0.063) 
-0.210 *** 
(0.047) 
-0.143 ** 
(0.068) 
SupInsu 0.144 * 
(0.083) 
0.003 
(0.065) 
0.204 *** 
(0.072) 
-0.035 
(0.089) 
0.133 * 
(0.069) 
0.013 
(0.053) 
0.176 *** 
(0.052) 
-0.106 
(0.066) 
SecEduc -0.009 
(0.039) 
-0.008 
(0.038) 
0.023  
(0.062) 
0.124 ** 
(0.058) 
0.089 
(0.074) 
-0.038 
(0.042) 
-0.048 
(0.035) 
0.052 
(0.061) 
TerEduc 0.034 
(0.082) 
-0.035 
(0.069) 
0.036  
(0.092) 
-0.043 
(0.102) 
0.270 
(0.191) 
0.058 
(0.089) 
0.001 
(0.064) 
0.209 ** 
(0.093) 
ADL 0.100 *** 
(0.029) 
0.088 *** 
(0.019) 
0.149 *** 
(0.041) 
-0.035 
(0.031) 
0.058 * 
(0.032) 
0.014 
(0.024) 
0.081 *** 
(0.017) 
0.083 ** 
(0.038) 
NCD 0.263*** 
(0.014) 
0.204 *** 
(0.014) 
0.151 *** 
(0.019) 
0.212 *** 
(0.019) 
0.107 *** 
(0.019) 
0.174 *** 
(0.012) 
0.165 *** 
(0.012) 
0.218 *** 
(0.019) 
SPGH -0.383 *** 
(0.043) 
-0.433 *** 
(0.041) 
-0.531 *** 
(0.073) 
-0.374 *** 
(0.057) 
-0.434 *** 
(0.074) 
-0.517 *** 
(0.044) 
-0.554 *** 
(0.037) 
-0.573 *** 
(0.062) 
UW 0.078 
(0.247) 
0.215 
(0.180) 
0.031  
(0.219) 
0.203 
(0.247) 
0.237 
(0.393) 
0.189 
(0.252) 
0.214 
(0.146) 
-0.053 
(0.229) 
OW 0.046 
(0.247) 
-0.012 
(0.037) 
-0.110  
(0.074) 
0.096 
(0.066) 
-0.136 ** 
(0.069) 
-0.106 ** 
(0.052) 
-0.047 
(0.037) 
0.018 
(0.058) 
OB 0.063 
(0.047) 
0.023 
(0.048) 
-0.132 * 
(0.073) 
0.120 * 
(0.063) 
0.057 
(0.086) 
-0.088 
(0.058) 
0.097 ** 
(0.045) 
0.024 
(0.074) 
Smoke 0.087 ** 
(0.039) 
0.021 
(0.035) 
0.124 *  
(0.061) 
-0.045 
(0.053) 
-0.029 
(0.070) 
0.029 
(0.042) 
0.024 
(0.038) 
0.074 
(0.051) 
alpha 0.871 (0.031) 
0.799 
(0.025) 
0.600  
(0.059) 
0.664 
(0.039) 
0.574 
(0.039) 
0.677 
(0.026) 
0.561 
(0.021) 
0.975 
(0.041) 
N  4624 4,944 1,472 1,639 1,481 4,007 4,942 3,708 
Notes: Standard deviations are in parentheses. ***, **, *, are the significance at level 1,5 and 10% respectively. Table 1: what countries correspond to each acronym 
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Table 5.  Zero-inflated negative binomial estimates. European Union.  
HS as dependent variable 
Variable 
50-65 
years  
65-75 
years  
75-85    
years 
+85 
years 
Female 
-0.224 *** 
(0.071) 
-0.178*** 
(0.066) 
-0.297 *** 
(0.075) 
0.158 
(0.104) 
Single 
0.413 *** 
(0.088) 
0.207 *** 
(0.072) 
0.209 *** 
(0.081) 
0.123 
(0.113) 
SupInsu 
0.169 ** 
(0.070) 
0.193 ** 
(0.078) 
0.064 
(0.071) 
1.674 *** 
(0.161) 
SecEduc 
0.077  
(0.088) 
0.252 *** 
(0.068) 
0.129 * 
(0.072) 
-0.241 
(0.194) 
TerEduc 
0.177  
(0.133) 
0.318 *** 
(0.124) 
-0.008 
(0.143) 
0.128 *** 
(0.024) 
ADL 
0.249 *** 
(0.041) 
0.381 *** 
(0.039) 
0.205 *** 
(0.028) 
0.249 
(0.270) 
NCD 
0.355 *** 
(0.025) 
0.258 *** 
(0.018) 
0.059 *** 
(0.019) 
-0.612 *** 
(0.141) 
SPGH 
-1.282 *** 
(0.076) 
-1.246*** 
(0.066) 
-0.769 *** 
(0.087) 
0.378 *** 
(0.109) 
UW 
0.622 * 
(0.333) 
0.912 *** 
(0.311) 
0.238 
(0.252) 
0.110 
(0.111) 
OW 
-0.237 *** 
(0.087) 
0.028 
(0.075) 
-0.127 
(0.082) 
0.008 
(0.152) 
OB 
-0.082 
(0.096) 
0.015 
(0.077) 
-0.086 
(0.088) 
0.046 * 
(0.026) 
Smoke 
0.237 *** 
(0.069) 
0.072 
(0.060) 
0.031 
(0.071) 
0.136 
(0.126) 
inflate cons 
-16.535 *** 
(0.282) 
-17.205 
(0.487) 
0.921 *** 
(0.105) 
1.538 
(0.173) 
alpha 
22.119 
(0.559) 
16.971 
(0.393) 
2.102 
(0.220) 
21.21 
(2.200) 
N 
(N=26,976) (N=21,063) (N= 12,436) 
(N= 3,305) 
Notes: Standard deviations are in parentheses. ***, **, *, are the significance at level 1,5 and 10% 
respectively. 
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Table 6. Zero-inflated negative binomial estimates. European countries. HS as dependent variable 
Variable AT BE CRO CR DE ES FR GE 
Age 0.041 *** 
(0.09) 
0.002 
(0.014) 
0.060 *** 
(0.019) 
0.043 *** 
(0.008) 
0.002 
(0.017) 
0.059 *** 
(0.015) 
-0.017 
(0.018) 
0.055 *** 
(0.009) 
Age2 -0.001 ** 
(0.0001) 
0.001 
(0.000) 
-0.001 *** 
(0.000) 
-0.001 ** 
(0.000) 
-0.001 
(0.000) 
-0.001 *** 
(0.000) 
0.001 
(0.000) 
-0.001 *** 
(0.000) 
Female 0.026 
(0.110) 
-0.286 ** 
(0.141) 
-0.153 
(0.184) 
0.058 
(0.105) 
0.023 
(0.173) 
-0.342 ** 
(0.144) 
-0.015 
(0.180) 
-0.158 * 
(0.091) 
Single 0.082 
(0.107) 
0.127 
(0.148) 
-0.129 
(0.206) 
0.202 * 
(0.107) 
0.212 
(0.162) 
0.461 *** 
(0.141) 
0.016 
(0.181) 
0.462 *** 
(0.106) 
InLabFor -0.214 
(0.186) 
-0.732 *** 
(0.197) 
-0.293 
(0.267) 
-0.260 
(0.160) 
-0.815 *** 
(0.235) 
-0.749 *** 
(0.202) 
-0.779 *** 
(0.256) 
-0.373 *** 
(0.125) 
SupInsu 0.461 *** 
(0.145) 
-0.303 
(0.188) 
0.714 ** 
(0.0358) 
-0.037 
(0.214) 
-0.294 * 
(0.173) 
0.048 
(0.219) 
0.147 
(0.396) 
0.064 
(0.093) 
SecEduc -0.001 
(0.112) 
0.346 ** 
(0.137) 
-0.143 
(0.183) 
0.077 
(0.118) 
0.289 
(0.199) 
-0.021 
(0.141) 
0.345 
(0.227) 
0.102 
(0.135) 
TerEduc -0.183 
(0.214) 
0.128 
(0.180) 
-0.209 
(0.609) 
0.031 
(0.173) 
1.347 *** 
(0.327) 
0.438 
(0.267) 
0.379 
(0.322) 
-0.226 
(0.184) 
ADL 0.119 *** 
(0.045) 
0.289 *** 
(0.072) 
-0.002 
(0.054) 
0.177 *** 
(0.033) 
0.316 ** 
(0.124) 
0.275 *** 
(0.048) 
0.294 *** 
(0.076) 
0.105 *** 
(0.035) 
NCD 0.184 *** 
(0.032) 
0.163 *** 
(0.042) 
0.129 ** 
(0.060) 
0.089 *** 
(0.028) 
0.344 *** 
(0.059) 
0.169 ** 
(0.066) 
0.143 ** 
(0.060) 
0.156 *** 
(0.034) 
SPGH -0.771 *** 
(0.120) 
-1.284 *** 
(0.153) 
-1.269 *** 
(0.296) 
-0.643 *** 
(0.111) 
-1.136 *** 
(0.196) 
-1.025 *** 
(0.223) 
-1.715 *** 
(0.191) 
-1.019 *** 
(0.123) 
UW -0.016 
(0.299) 
-0.826 ** 
(0.371) 
0.099 
(0.440) 
0.507 
(0.681) 
0.741 
(0.789) 
-0.489 
(0.339) 
0.654 
(0.548) 
0.759 *** 
(0.227) 
OW -0.036 
(0.119) 
-0.106 
(0.154) 
0.207 
(0.202) 
-0.146 
(0.124) 
-0.207 
(0.199) 
-0.353 ** 
(0.169) 
0.206 
(0.199) 
0.050 
(0.105) 
OB -0.029 
(0.132) 
0.172 
(0.178) 
-0.037 
(0.241) 
-0.215 * 
(0.125) 
-0.4431 * 
(0.252) 
-0.386 ** 
(0.157) 
-0.013 
(0.241) 
0.162 
(0.121) 
Smoke 0.194 * 
(0.105) 
0.268 ** 
(0.131) 
-0.326 ** 
(0.181) 
0.162 * 
(0.093) 
0.007 
(0.169) 
0.051 
(0.124) 
0.449 *** 
(0.171) 
0.073 
(0.093) 
infl cons 0.671 *** (0.132) 
-14.436 
*** (0.529) 
1.442 *** 
(0.266) 
1.146 *** 
(0.067) 
-14.864 
*** (0.268) 
0.0886 *** 
(0.296) 
-13.074 
*** (0.534) 
0.909 *** 
(0.094) 
alpha 1.852 (0.339) 
14.529 
(0.694) 
2.323 
(0.927) 
1.430 
(0.181) 
16.154 
(1.134) 
3.567 
(1.287) 
17.564  
(0.063) 
1.663 
(0.237) 
N  3,266 5,370 2,294 4,612 3,499 5,356 3,718 4,233 
Notes: Standard deviations are in parentheses. ***, **, *, are the significance at level 1, 5 and 10% respectively. Table 1: what countries correspond to each acronym 
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Table 6. Zero-inflated negative binomial estimates. European countries. HS as dependent variable (continuation) 
 
Variable GR IT LU PL PO SL SP SW 
Age -0.425 *** 
(0.114) 
0.014 
(0.029) 
0.061 *** 
(0.015) 
0.091 *** 
(0.11) 
-0.820 *** 
(0.251) 
 -0.223 * 
(0.126) 
0.023 * 
(0.013) 
-0.041 *** 
(0.014) 
Age2 0.003 *** 
(0.001) 
-0.001 
(0.000) 
-0.004 *** 
(0.000) 
-0.001 *** 
(0.000) 
0.006 *** 
(0.002) 
0.002 * 
(0.001) 
-0.001 
(0.000) 
0.001 *** 
(0.000) 
Female -0.773 *** 
(0.207) 
-0.484 *** 
(0.167) 
-0.143 
(0.188) 
-0.036 
(0.172) 
-0.891 *** 
(0.276) 
-0.228 
(0.139) 
-1.003 *** 
(0.175) 
-0.196 
(0.149) 
Single 0.285 
(0.211) 
0.169 
(0.185) 
0.462 ** 
(0.195) 
0.219 
(0.185) 
0.483 
(0.331) 
0.173 
(0.45) 
0.548 *** 
(0.204) 
0.160 
(0.176) 
InLabFor -0.307 
(0.246) 
-0.301 
(0.232) 
-0.689 ** 
(0.285) 
-0.512 * 
(0.279) 
-0.250 
(0.364) 
-0.729 *** 
(0.261) 
-1.006 *** 
(0.231) 
-0.469 ** 
(0.209) 
SupInsu 0.413 
(0.378) 
-0.139 
(0.352) 
0.368 ** 
(0.186) 
0.402 
(0.379) 
-0.015 
(0.279) 
-0.149 
(0.149) 
0.682 ** 
(0.268) 
0.113 
(0.223) 
SecEduc -0.818 *** 
(0.210) 
0.268 
(0.193) 
-0.213 
(0.166) 
0.036 
(0.158) 
-0.337 
(0.326) 
-0.233 
(0.142) 
-0.109 
(0.167) 
0.084 
(0.166) 
TerEduc -0.673 * 
(0.363) 
0.149 
(0.284) 
-0.582 ** 
(0.269) 
0.373 
(0.486) 
-1.239 *** 
(0.459) 
-0.582 * 
(0.327) 
-0.919 *** 
(0.286) 
0.178 
(0.250) 
ADL 0.464 *** 
(0.095) 
0.271 *** 
(0.091) 
0.341 *** 
(0.077) 
-0.022 
(0.041) 
0.398 *** 
(0.111) 
0.154 *** 
(0.059) 
0.379 *** 
(0.089) 
0.188 ** 
(0.085) 
NCD 0.307 *** 
(0.064) 
0.266 *** 
(0.072) 
0.074 * 
(0.045) 
0.065 
(0.042) 
0.191 *** 
(0.071) 
0.183 *** 
(0.052) 
0.197 *** 
(0.053) 
0.234 *** 
(0.049) 
SPGH -1.98 *** 
(0.192) 
-1.825 *** 
(0.185) 
-0.829 *** 
(0.178) 
-0.973 *** 
(0.198) 
-1.094 *** 
(0.320) 
-0.918 *** 
(0.165) 
-1.733 *** 
(0.167) 
-0.924 *** 
(0.153) 
UW 1.150 
(0.949) 
1.173 
(0.845) 
1.285 *** 
(0.484) 
0.636 
(0.605) 
-0.693 
(0.625) 
0.391 
(0.414) 
0.186 
(0.571) 
0.504 
(0.528) 
OW 0.136 
(0.207) 
-0.181 
(0.178) 
-0.366 * 
(0.202) 
-0.380 ** 
(0.181) 
-0.916 *** 
(0.283) 
-0.344 ** 
(0.156) 
-0.545 *** 
(0.192) 
-0.008 
(0.174) 
OB 0.520 * 
(0.276) 
-0.242 
(0.189) 
0.074 
(0.196) 
-0.291 * 
(0.174) 
-0.931 ** 
(0.384) 
-0.332 * 
(0.189) 
-0.239 
(0.211) 
0.288 
(0.202) 
Smoke 0.081 
(0.195) 
0.034 
(0.148) 
0.172 
(0.178) 
-0.059 
(0.156) 
-0.262 
(0.278) 
0.184 
(0.129) 
-0.098 
(0.169) 
0.113 
(0.148) 
infl cons -13.354*** (0.383) 
-0.415 
(2.198) 
1.217 *** 
(0.158) 
1.239 *** 
(0.093) 
-12.636*** 
(1.416) 
0.951 *** 
(0.232) 
-14.716*** 
(0.368) 
-13.059 *** 
(2.236) 
alpha 23.936 (0.073) 
11.775 
(12.363) 
1.789 
(0.440) 
1.354 
(0.211) 
20.623 
(1.895) 
3.019 
(0.903) 
19.534 
(1.069) 
14.632 
(0.089) 
N  4,624 4,944 1,472 1,639 1,481 4,007 4,942 3,708 
Notes: Standard deviations are in parentheses. ***, **, *, are the significance at level 1, 5 and 10% respectively. Table 1: what countries correspond to each acronym 
 
 
 
 
 
